SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

CGTX Reports Q3 Loss, Alzheimer’s Study Enrollment and Zervimesine Patent Update

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.

CGTX

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.

Related stories